We have identified and characterized the Escherichia coli gene dsbB, whose product is required for diaulfide bond formation of periplasmic proteins, by using two different approaches: (i) screening of a multicopy plasmid library for clones which protect E. coli from the lethal effects of dithiothreitol (DTT), and (ii) screening of insertion libraries of E. coli for DTT-sensitive mutants. Mapping and characterization of mutations conferring a DTT-sensitive phenotype also identified the dsbA, trxA, and trxB genes, whose products are involved in different oxidation-reduction pathways. Null mutations in dsbB conferred pleiotropic phenotypes such as sensitivity to benzylpenicillin and inability to support plaque formation of filamentous phages, and they were shown to severely affect disulfide bond oxidation of secreted proteins such as OmpA and &3lactamase. These phenotypes resemble the phenotype of bacteria carrying either a null mutation in the dsbA gene or the double mutation dsbA dsbB. Sequencing and expression of the dsbB gene revealed that it encodes a 20-kDa protein predicted to possess an "exchangeable" disulfide bond in -Cys-Val-Leu-Cys-. The dsbB gene maps at 26.5 min on the genetic map of the E. coil chromosome, and its transcription is directed from two promoters, neither of which resembles the canonical Eo7'-recognized promoter.
Relatively little is understood thus far regarding the process of folding and assembly of secreted proteins in prokaryotes. Exported proteins face a harsher environment in the periplasm, since this space is more vulnerable to environmental stresses than is the cytosol (1) . It is thus reasonable to expect that in Escherichia coli there may be periplasmic chaperones whose function is to ensure the proper folding and maintenance of periplasmic proteins. Another expected class of proteins is enzymes that can either directly catalyze disulfide bond formation or maintain an appropriate oxidized environment in the periplasm. It is indeed well established that the vast majority of disulfide bond-containing proteins are either secreted or integral membrane proteins, since the bacterial cytoplasm is a comparatively reducing environment (2) . Thus it is quite important that in E. coli a periplasmic protein, designated DsbA, was recently discovered and shown to be involved in disulfide bond formation (3) . DsbA has been characterized in vivo as well as in vitro (3) (4) (5) . It has been shown that in dsbA mutants a variety of secreted proteins lack disulfide bonds (3, 4) .
In an attempt to identify genes whose products are involved in the stability or assembly of proteins in the periplasmic space, we initiated a series of experiments utilizing various genetic approaches. In the present study, we took advantage of the phenotypes of either resistance or sensitivity to strong reducing agents such as dithiothreitol (DTT) to
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
characterize gene products involved in the oxidation and/or reduction pathways. In one approach, a multicopy E. coli genomic library was used to identify those proteins whose overproduction would protect bacteria against the lethal reducing effects of DTT. In a complementary approach, insertional mutants that exhibited hypersensitivity to sublethal concentrations of DTT were isolated. Both studies identified the existence of a gene designated dsbB. § A null mutation in dsbB leads to the pleiotropic phenotype, similar to the one exhibited by dsbA null mutants, of deficiency in disulfide bond formation of secreted proteins such as OmpA and ,B-lactamase. These results are consistent with independent studies (6, 7) also reporting the identification ofthe dsbB gene. The insertional mutational approach for DTT sensitivity also resulted in the isolation of mutations in the known genes trxA (encoding thioredoxin), trxB (encoding thioredoxin reductase), and the recently described dsbA (3, 4, 8) .
MATERIALS AND METHODS
Selection Strategies and Cloning of dsbB. Chromosomal DNA isolated from E. coli wild-type strain MC4100 was subjected to partial digestion with Sau3A to produce DNA fragments 2-6 kb in length. These DNA fragments were gel-purified and ligated into the BamHI site of the plSAbased vector pOK12. A library of at least 20,000 independent recombinant clones was made, and DNA from such a pool was used to transform various wild-type E. coli strains. Twenty-four plasmid clones whose presence conferred resistance to otherwise lethal DTT levels (20 mM) were thus selected. The restriction enzyme digestion pattern ofthese 24 plasmids showed that they all carried the same chromosomal insert. Plasmid clones pDM243 and pDM244, which carry the same 1.5-kb Sau3A fragment but in opposite orientations with respect to the T7 promoter of the pOK12 vector, were retained and shown to contain dsbB. Subcloning ofthe 950-bp Kpn I-Sau3A fragment, which contains the minimal dsbB gene, resulted in plasmid pDM353 (Table 1) .
The overexpression of DsbB was achieved by first amplifying the dsbB gene minimal coding region by the PCR method (14) , using primers 5'-GGAGCGCCGAATGGATC-CGCGACCGAA-3' and 5'-TATTGCAGGCATATGAATA-TGTTG-3' and cloning in the T7 promoter expression vector pET-3a (pDM507). The dsbA gene (1.8-kb Sau3A DNA fragment) was cloned, using the genomic library described above (pSR1865), by selecting for its ability to complement SR1790 (dsbAIOI::TnlO) and DM547 (dsbA43::TnlO) mutant bacteria and was verified by its ability to recombine with various TnlO insertions within the dsbA gene.
Abbreviations: DTT, dithiothreitol; DTNB, 5,5'-dithiobis(2-nitrobenzoic acid); Kanr, kanamycin resistance.
*To whom reprint requests should be sent at the t address. §The sequence reported in this paper has been deposited in the GenBank data base (accession no. L03721).
Proc. Natl. Acad. Sci. USA 90 (1993) 7085 (18) . To probe for dsbB message, 100 ng of the 280-bp Nsi I-Hpa I DNA fragment (internal to the dsbB gene) was isolated from pDM353 and 32P-labeled with [a-32P]dATP (3000 Ci/mmol; 1 Ci = 37 GBq) using the nick-translation procedure (18) . To define the transcriptional start sites, -10 ng of the oligonucleotide probe 5'-ACTGCTCTGGCACTG-GAACTG-3', which is complementary to nucleotide positions 66-86 of the dsbB sequence, was annealed with 10 ,ug of total cellular RNA. The annealed primer was extended by reverse transcriptase from avian myeloblastosis virus, essentially as described (9) . The primer extension products were electrophoresed on the same gel as the dideoxy sequencing reaction products, using the same primer.
Labeling, Fractionation, and Immunoprecipitation. For labeling of proteins, cells were grown in M9 minimal medium (18) , supplemented with each of the amino acids (except methionine and cysteine) at 20 ug/ml and 0.4% glucose. Bacterial cultures were pulse-labeled with [35S]methionine at 100 ,uCi/ml for 45 sec followed by a 1000-fold excess of unlabeled methionine. Disulfide bond formation in OmpA and 3-lactamase was assessed by the method described by Pollitt and Zalkin (19) . The anti-OmpA antiserum was a kind gift of S. Mizushima, and anti-t3-lactamase antibody was purchased from 5 Prime --3 Prime, Inc.
RESULTS
Cloning of dsbB. In an attempt to identify genes whose products are involved in protein stabilization, particularly in the periplasm, we selected for tolerance to otherwise lethal levels of DTT, a reducing agent that has been shown to reduce a variety of proteins, including protein disulfide isomerase and thioredoxin. Thus, it is expected that the presence of high amounts of DTT will result in the misfolding of many proteins which require disulfide bond(s) to achieve their functional native form. Overexpression of either a chaperone or a cellular component able to catalyze or to participate in disulfide exchange reactions may relieve the cells of DTT's toxic effect. A library of E. coli chromosomal DNA prepared in the p15A-based vector pOK12 was used to select for clones which enable wild-type E. coli to form colonies on L agar (18) supplemented with 20 mM DTT, a concentration at which wild-type bacteria do not normally grow. Twenty-four large colony formers were thus isolated and subsequently shown to share an identical 1.5-kb Sau3A DNA fragment (pDM243 and pDM244). Further subcloning experiments showed that DNA sequences required to confer resistance to DTT were present on a 950-bp Kpn I-Sau3A fragment (pDM353), defining the dsbB gene.
Mapping of dsbB. We hybridized the 32P-labeled 1.5-kb Sau3A fragment derived from plasmid pDM243 (dsbB+) to the E. coli DNA library in bacteriophage A (16) . Hybridization was observed with bacteriophages A243 (2A3) and A244 (11G8), which carry the overlapping region corresponding to kbp 1235-1245 of the E. coli physical map. Further comparisons of the restriction maps of the dsbB+ subclones containing the 950-bp Kpn I-Sau3A fragment with the restriction map of E. coli covering this region confirmed that dsbB is located in the 1238-kbp region, corresponding to the 26.5-min region of the recalibrated E. coli genomic map (20) . Since the umuC gene, whose product is required for inducible mutagenesis, also maps in this region, we used plasmids pSE114 and pSE116 (10) to verify our results. We found that, whereas both plasmids carry the umuCD genes, pSE114 also contains the dsbB gene; thus we were able to place dsbB immediately upstream of umuCD. The position of dsbB was also verified genetically by using the umuC122::TnS as a marker for bacteriophage P1 transduction experiments with our dsbB::TnlO isolates. (Fig. 1) . The predicted sequence of the DsbB protein also shows at least three potential transmembrane domains (Fig. 1) , indicating a potential cytoplasmic membrane location. Upstream of the dsbB ORF we found a truncated ORF that corresponds to the end of the nhaB gene, encoding the Na+/H+ antiporter (21) . The recently reported nhaB sequence includes part of the dsbB ORF (21) . However, this sequence differs from ours by an extra base at position 794, leading to a frameshift in the dsbB sequence, and at position 479 (G vs C), leading to amino acid change from glycine to alanine (amino acid residue 52) of the DsbB protein (Fig. 1) .
The positions of two of the six dsbB: :TnJO insertions, able to recombine with the dsbB+-carrying plasmid pDM243, were determined by sequencing the DNA junction between TnJO and the dsbB gene, using primer reading out of the TnJO ends. The sites of the mini-Tet::TnJO insertions in DM391 and SR1753 were found to be within the deduced dsbB gene at nucleotide positions 36 and 65, respectively, from the putative ATG initiation codon (Fig. 1) .
To identify the dsbB gene product we used [35S]methionine to label BL21(DE3) cells carrying either plasmid pDM353 or pDM507, which contain the dsbB gene under the exclusive T7 promoter expression system (12) . When the T7 promoter was induced, a simultaneous induction of an -20-kDa protein was observed, consistent with the predicted size of DsbB protein (Fig. 2) .
Phenotypic Characterization and Mapping of DTT-Sensitive Mutants. Seventy-eight DTT-sensitive TnlO (Kanr) or TnlO (Tetr) insertions were isolated as described in Materials and Methods. Of these, six mutations were shown to map in the dsbB gene and two in the dsbA gene. Among the other genes identified in this screen were the trxA (SR1789) and trxB (SR1748) genes ( Table 1 ). The trxA and trxB genes have been shown to encode thioredoxin and thioredoxin reductase, respectively (8) . The majority of the DTT-sensitive mutants were found to share the following phenotypes: (i) hypersensitivity to benzylpenicillin, especially the dsbB and dsbA null mutant bacteria, with dsbB being more sensitive (15 ,g/ml); (ii) reduced overall expression of alkaline phosphatase [this phenotype was assayed by first transducing these mutations, by using bacteriophage P1, into strain RP6866, which con- tains plasmid pJJ20 carrying an in-frame TnphoA fusion at codon 84 of the motB gene (11)]; (iii) inability to support plaque formation of filamentous bacteriophages such as M13 or fl. These pleiotropic phenotypes suggested a generalized defect in the maturation of translocated proteins. Since the DsbB protein is predicted to lie in the membrane and to possess a disulfide bond active site, we tested whether these defects could be due to the accumulation of reduced forms of periplasmic proteins. Hence, we performed a quantitative analysis of periplasmic fractions prepared by osmotic shock (22) from DTT-sensitive mutant bacteria; the analysis used Ellman's reagent, 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) (23) . Interestingly, the incubation of the periplasmic fraction with an excess of DTNB (0.8 mM) resulted in a significant increase in absorbance at 412 nm due to formation of the 5-thio-2-nitrobenzoate ion, as compared with the absorbance observed with the extracts prepared from wild-type bacteria (Table 2) .
Oxidized DTT Can Suppress Phenotypic Defects Exhibited by dsbB Mutant Bacteria. We further confirmed that the phenotypes observed with dsbB null mutant bacteria were due to defects in disulfide bond formation by testing the ability of oxidized DTT to revert phenotypes such as hypersensitivity to benzylpenicillin. It has been shown that the penicillin-binding protein 4 (PBP4) has two disulfide bridges, which are predicted to be essential for its enzymatic activity (deacylation of benzylpenicillin) (24) . Thus, we reasoned that hypersensitivity of dsbB mutant bacteria to benzylpenicillin could be due to the (22) were prepared from the three isogenic strains harvested at OD595 = 0.4 in 50 mM sodium phosphate buffer, pH 7.5, containing 1 mM EDTA and 1 mM phenylmethanesulfonyl fluoride. DTNB prepared in the same buffer was added to each sample to a final concentration of 0.8 mM. The reaction at equilibrium was assessed by measuring the absorbance at 412 nm.
lack of disulfide bridges in PBP4. In agreement with this assumption, we observed that the addition of submillimolar amounts of oxidized DTT (0.2 mM) to the growth medium restored the colony-forming ability of all six dsbB::TnlO mutant bacteria to the wild-type level on L-agar plates supplemented with benzylpenicillin (50 ,g/ml). A similar phenotypic suppression by supplementation with oxidized DTT was obtained with bacteria carrying either the dsbAlOl::TnlO or the dsbA43::TnlO mutation. Taken together, these results suggest an important role ofthe DsbB protein in disulfide bond formation of a variety of proteins such as PBP4.
Disulfide Bond Formation of OmpA and -Lactamase Is Altered in a dsbB Null Mutant. More direct evidence that DsbB can facilitate disulfide bond formation in vivo was sought by using two different secreted proteins as substrates, OmpA and ,B3lactamase. Proteins were labeled by pulse-chase and then directly treated with iodoacetamide (modifying cysteine residues) or pretreated with DTT in the control experiments, as described by Pollitt and Zalkin (19) . The different forms of immunoprecipitated OmpA and 1-lactamase were separated by SDS/PAGE. Fig. 3 shows the pattern of migration of reduced and oxidized proteins, corresponding respectively to retarded and faster-migrating species. Immediately after the chase (time 0 min), -lactamase (Fig. 3A) or OmpA (Fig. 3B) was found to be mostly oxidized in wild-type bacterial backgrounds. In contrast, these proteins were found primarily in a reduced state in the null mutant strain dsbB-(DM391) (Fig. 3) and remained so, even after 10 min of chase. Similar results were obtained with bacteria carrying null mutations either in dsbA (SR1790) or in both dsbA and dsbB (SR1855). Transcriptional Regulation of dsbB. Northern analysis of dsbB transcripts showed that the gene is transcribed as a monocistronic message of -650 nt. As seen in Fig. 4 , the dsbB mRNA levels did not substantially change after a shift up in temperature from 300 to 42°C. Thus the dsbB gene does not appear to be regulated by heat shock.
Primer extension analysis was used to identify the 5' termini of dsbB-specific mRNA species. It was found that dsbB transcription is initiated from two sites, designated as P1 and P2, located 237 and 40 nt upstream of the putative ATG initiation codon (Fig. 5) . Interestingly, the P1 transcriptional start site is located within the coding region ofthe nhaB gene. The -10 and -35 regions corresponding to the two transcriptional start sites do not resemble canonical Ecr70-transcribed promoters or those recognized by RNA polymerase coupled with any other known o factors. Comparison of efficiency ofpromoter usage in different genetic backgrounds clearly shows that the more distal promoter P1 is more frequently utilized in wild-type bacteria, as judged by the relative amounts of transcripts. In contrast, transcripts initiated from the P2 start site were found to be more abundant when RNA was analyzed from isogenic bacterial strains carrying a null mutation in the rpoH (25) , katF (26) , or lrp (27) gene, encoding o.32, CyS, and leucine response regulatory proteins, respectively. The efficiency of the P2 promoter usage in rpoHA (oa32) strains is higher than that found for the wild type or katF or lrp mutant bacteria (Fig. 5 ).
DISCUSSION
We used two complementary approaches which resulted in the identification of an E. coli gene, dsbB, whose product is involved in disulfide bond formation of periplasmic proteins. The first approach was to select for genes whose presence on a multicopy plasmid enabled E. coli to survive the otherwise lethal effect of DTT (20 mM). All 24 clones isolated in this screen carried the dsbB+ gene (although in reconstruction experiments we showed that the dsbA gene on the same multicopy plasmid enabled E. coli to form colonies, although smaller, in the presence of DTT). The second approach was to screen for insertional mutations which result in increased sensitivity to 7 mM DTT, a concentration that wild-type cells can tolerate. One of the major targets of insertional mutations was the dsbB gene. We found that inactivation of the trxA and trxB genes (8) and the dsbA gene (3, 4) also resulted in hypersensitivity to DTT. Thus, it appears that mutations in genes whose products are involved in maintaining an oxidation-reduction balance, either in the periplasm or in the cytosol, lead to DTT sensitivity.
In this work, we have presented different lines of evidence which demonstrate that in vivo there is a strong requirement for DsbA, DsbB, or both, to oxidize disulfide bonds of variety of proteins. Consequently, null mutations in the dsbB gene were shown to confer a highly pleiotropic phenotype similar to that observed in dsbA mutants, such as (i) inability to support plaque-forming ability of filamentous bacteriophages such as M13 [such a phenotype may be due to lack of F pili, as has been reported for dsbA mutants (3)]; (ii) reduced expression of periplasmic secreted proteins such as alkaline phosphatase; (iii) accumulation of reduced forms of the secreted proteins OmpA and l3-lactamase in the periplasm, as judged by direct comparison of amounts of oxidized versus reduced forms of these proteins; (iv) sensitivity to drugs such as benzylpenicillin whose target is penicillin-binding protein 4 , which has two disulfide bridges as part of its active site; and (v) overall accumulation of proteins with reduced cysteines in the periplasm as assayed with DTNB. The fact that these phenotypic defects could be overcome by supplementation with submillimolar amounts of oxidized DTT clearly showed that DsbB is involved in the oxidation of disulfide bonds of substrate proteins.
Since null mutations in either dsbA or dsbB alone or in both dsbA and dsbB exhibit identical phenotypes, most likely DsbA and DsbB are part of the same periplasmic pathway of disulfide oxidation-reduction. DsbA has been shown to be a disulfide oxidase capable of oxidizing substrate proteins, such as alkaline phosphatase and ribonuclease A (5), or reducing oxidized insulin (3); hence, it is likely that the role of DsbB is to oxidize reduced forms of DsbA, thus allowing recycling of active DsbA. It is also possible that DsbB is able to directly oxidize other periplasmic proteins in a substratespecific or nonspecific manner. In this case, DsbA would be simply another substrate of DsbB. The independent study from Bardwell et al. (6) favors the model where DsbB preferentially oxidizes DsbA. Examination of the DsbB sequence leads to the prediction that it is an integral membrane protein with a CXXC motif in the periplasmic space, which is consistent with such a disulfide oxidase role for the protein.
The putative membrane localization of DsbB raises the possibility of its coupling to a membrane electron transport system, thus enabling its reoxidation and recycling. If DsbA and DsbB proteins are indeed part of the same pathway, it is very likely that genes homologous to dsbB will be found in other organisms, as is the case for the dsbA gene (28) (29) (30) .
An interesting point concerns the type of transcriptional regulation to which the dsbB gene is subjected. Although two promoters were found, neither was related to any known consensus promoter sequence. The P2 promoter was activated in the absence of gene products, such as o.32, as, or the leucine-responsive regulatory protein, involved in the transcription of groups of genes under special growth conditions. Perhaps, the P2 promoter is responsible for ensuring continuous transcription of the dsbB gene under a variety of stresses since, under the same conditions, transcription from the P1 promoter is drastically diminished.
